Christopher Carlos, MD, MAS
Assistant Professor
Medicine
School of Medicine

Dr. Christopher Carlos is an Assistant Professor within the Division of Nephrology and a board-certified nephrologist. He practices both inpatient and outpatient nephrology. In his outpatient clinic, he specializes in treating patients with acute kidney injury, chronic kidney disease, end-stage kidney disease, hypertension, electrolyte imbalances and glomerular disorders.

Show full bio (80 words) Hide full bio

Dr. Carlos earned his medical degree from Case Western Reserve University School of Medicine. He completed his residency in Internal Medicine at UCSF, where he also completed a fellowship in Nephrology. During his fellowship, he obtained a Master's Degree in Clinical Research from the UCSF School of Epidemiology and Biostatistics. His primary research interest was in the effect of dialysis therapies on physical function and well-being.

He is a member of the American Society of Nephrology and National Kidney Foundation.

Education & Training

Show all (5) Hide

• MAS Clinical Research UCSF 2019
• Fellowship Nephrology UCSF 2018
• Residency Internal Medicine UCSF 2016
• MD School of Medicine Case Western Reserve University 2013
• BA Human Biology Stanford University 2007

Interests

Show all (6) Hide

• Kidney Disease in Cancer Patients
• Proteinuria
• Kidney Vasculitis
• Hypertension
• Diabetic Nephropathy
• Glomerular Disease

Grants and Projects

Show all (1) Hide

• Dialysis Rx to Yield Optimal UltrafilTration (DRYOUT), NIH, 2018-2020

Publications (7)

Top publication keywords:
Water-Electrolyte ImbalanceCohort StudiesImmunotherapyLongitudinal StudiesEarly Detection of CancerIncidenceWalking SpeedColorectal NeoplasmsAcute Kidney InjuryColonic NeoplasmsImmunologic FactorsGaitKidney Failure, ChronicHospitalizationRenal Dialysis

• Acute kidney injury in patients treated with immune checkpoint inhibitors.
  Journal for immunotherapy of cancer 2021 Gupta S, Short SAP, Sise ME, Prosek JM, Madhavan SM, Soler MJ, Ostermann M, Herrmann SM, Abudayyeh A, Anand S, Glezerman I, Motwani SS, Murakami N, Wanchoo R, Ortiz-Melo DI, Rashidi A, Sprangers B, …
• Predialysis fluid overload and gait speed: a repeated measures analysis among patients on chronic dialysis.
  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2020 Carlos C, Grimes B, Segal M, Johansen K
• Acute Kidney Injury with Immune Checkpoint Inhibitors: A Push beyond Case Reports.
  Clinical journal of the American Society of Nephrology : CJASN 2019 Carlos CA, Hsu RK
• Colon Cancer Screening among Patients Receiving Dialysis in the United States: Are We Choosing Wisely?
  Journal of the American Society of Nephrology : JASN 2017 Carlos CA, McCulloch CE, Hsu CY, Grimes B, Pavkov ME, Burrows NR, Shahinian VB, Saran R, Powe NR, Johansen KL, Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team
• Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI.
  Journal for immunotherapy of cancer 2022 Gupta S, Garcia-Carro C, Prosek JM, Glezerman I, Herrmann SM, Garcia P, Abudayyeh A, Lumlertgul N, Malik AB, Loew S, Beckerman P, Renaghan AD, Carlos CA, Rashidi A, Mithani Z, Deshpande P, Rangarajan …
• Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.
  Kidney international 2022 Gupta S, Strohbehn IA, Wang Q, Hanna PE, Seethapathy R, Prosek JM, Herrmann SM, Abudayyeh A, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, de Seigneux S, …
• Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study
  Journal of Onco-Nephrology. 2021 Natsuhara KH, Zhang L, Carlos CA, Borno HT.